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E-mail: jean-christophe.lagier@ap-hm.frPaenibacillus spp. have been isolated from various sources
including soil, water, the plant rhizosphere, plant materials, food,
fodder, faeces and diseased insect larvae [1], but they are not
usually associated with clinical infection. Here we report the ﬁrst
case of bone infection caused by Paenibacillus turicensis, and we
describe a second human infection due to this bacterium [2].
A 65-year-old man with a medical history of high blood
pressure and arterial disease had a motorbike accident during a
trip in Vientiane, Laos, in October 2014. He experienced
fractures to both the tibia and ﬁbula. He underwent surgical
treatment in Vientiane (centromedullar nail), with 5 days’
treatment with an unknown antibiotic agent. Late bone healing
caused pain without fever, turgor or purulence. A second
surgical procedure was performed in March 2015 in Marseille,
France, with deep samples, ablation of the centromedullar nail
and replacement with a new one. The culture was positive for
Gram-positive bacteria, unidentiﬁed by conventional pheno-
typic methods (Vitek 2; bioMérieux, Marcy l’Étoile, France). The
strain was sent to the La Timone laboratory in Marseille for 16SNew Microbes and New Infections © 2016 The Authors. Published by El
This is an open access artirRNA gene ampliﬁcation and sequencing. This isolate shared
99.7% sequence similarity with the reference sequence of
Paenibacillus turicensis available in GenBank (HM069128.1).
Antibiotic susceptibility testing by the diffusion method
revealed susceptibility to amoxicillin, aminoglycosides, cipro-
ﬂoxacin, rifampicin and vancomycin. Medical treatment was
introduced for 6 months (amoxicillin 7 g per day) because of
the impossibility of removing the osteosynthesis equipment.
The outcome after 6 months’ follow-up was favourable, with
clinical and radiologic consolidation.
The name turicensis is an adjectival form of the word Turicum,
the Latin name for Zurich, where the type strain was ﬁrst
isolated. This Gram-positive, facultative aerobic bacterium was
ﬁrst identiﬁed and described by Bosshard et al. [2] in 2002 from
the valve of a cerebrospinal ﬂuid shunt of a 48-year-old man
with hydrocephalus. Since this discovery, Paenibacillus turicensis
has not been cultured from another clinical sample. Never-
theless, this species was identiﬁed by 16S rRNA gene
sequencing performed from unidentiﬁed growing colonies on
samples from a paper mill environment in Finland (papermaking
chemicals, broken plants and water) [3].
To our knowledge, only two cases of bone infections caused
by Paenibacillus spp. have previously been described. One was a
bone infection due to P. thiaminolyticus identiﬁed by 16S rRNA
gene PCR on growing colonies from samples under anaerobic
conditions, and the other was a case of sternitis caused byNew Microbe and New Infect 2016; 11: 45–46
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negative sample [4,5]. In their study, Siala et al. [6] used bac-
terial 16S rRNA gene primers in broad-range PCR to screen for
the presence of bacterial DNA in culture-negative synovial ﬂuid
from patients with reactive and other forms of arthritis. Pae-
nibacillus spp. was identiﬁed several times.
The increased number of recognized bacteria and of bacteria
isolated in human samples is caused by two successive revolutions
in the ﬁeld of bacterial identiﬁcation allowed by 16S rRNA
ampliﬁcation and sequencing [7] and more recently by the
increasing use of matrix-assisted laser desorption/ionization time-
of-ﬂight mass spectrometry in clinical microbiology laboratories
[8]. Online databases can help clinicians and microbiologists to
assess the pathogenicity of unusual bacterial isolates (http://hpr.
mediterranee-infection.com/arkotheque/client/ihu_bacteries/
recherche/index.php) [9]. This case report reminds clinicians of
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